Hypertension News

Researchers have said that hypertension is a major risk factor for cardiovascular disease which is a leading cause of death in IndiaOnly 5.3% of hypertensive men and 10.9% of hypertensive women aged 15-49 years have their blood pressure under control

US FDA says Aurobindo Pharma has initiated recall of 22 batches of drug substance Irbesartan, used in treatment of hypertension, from the US market due to the presence of an impurity, which is believed to cause cancer

Hetero Labs is recalling 15,94,092 bottles of Valsartan Tablets USP in the strengths of 40 mg, 80 mg, 160 mg and 320 mg, manufactured by the firm for Camber Pharmaceuticals, USFDA said in a report

Screening for diabetes should be performed in all individuals who are more than 30 years of age, the ICMR guidelines say

Low socio-economic status is consistently associated with higher rates of non communicable diseases such as cancer, heart disease and kidney diseases in low and middle-income countries, a study shows

Central Drug Standards Control Organisation has initiated an inquiry against Zydus Cadila, Eris Lifesciences and Intas Pharmaceuticals for selling hypertension drug without approval

Apollo Munich Health Insurance is set to provide specialized care to those affected lifestyle diseases such as heart ailments, cancer and hypertension

The health ministry has already sanctioned Rs955 crore in 2017-18 for tackling lifestyle diseases such as cardiovascular disease, hypertension, obesity and diabetes

Pharma regulator CDSCO has initiated an inquiry against Zydus Cadila and Intas Pharma after receiving a complaint from Hetero Drugs conducting clinical trials for the same hypertension drug

Drug maker Lupin launches Olmesartan Medoxomil tablets, a hypertension drug, in the US market